CA2960519A1 - Systeme et procede d'administration de medicaments - Google Patents
Systeme et procede d'administration de medicaments Download PDFInfo
- Publication number
- CA2960519A1 CA2960519A1 CA2960519A CA2960519A CA2960519A1 CA 2960519 A1 CA2960519 A1 CA 2960519A1 CA 2960519 A CA2960519 A CA 2960519A CA 2960519 A CA2960519 A CA 2960519A CA 2960519 A1 CA2960519 A1 CA 2960519A1
- Authority
- CA
- Canada
- Prior art keywords
- medication
- sensor circuit
- transmission hub
- application
- information
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 title claims abstract description 262
- 229940079593 drug Drugs 0.000 title claims abstract description 258
- 238000000034 method Methods 0.000 title claims abstract description 35
- 230000005540 biological transmission Effects 0.000 claims abstract description 105
- 230000008569 process Effects 0.000 claims abstract description 8
- 238000004891 communication Methods 0.000 claims description 28
- 238000012544 monitoring process Methods 0.000 claims description 17
- 238000001514 detection method Methods 0.000 claims description 10
- 230000000977 initiatory effect Effects 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 2
- 229940090047 auto-injector Drugs 0.000 description 9
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 238000004806 packaging method and process Methods 0.000 description 8
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 229930182837 (R)-adrenaline Natural products 0.000 description 6
- 229960005139 epinephrine Drugs 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 108010072051 Glatiramer Acetate Proteins 0.000 description 3
- 229940112141 dry powder inhaler Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 3
- 229960004127 naloxone Drugs 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229940038717 copaxone Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 229940071648 metered dose inhaler Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000006199 nebulizer Substances 0.000 description 2
- 238000012015 optical character recognition Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 230000005355 Hall effect Effects 0.000 description 1
- FHEAIOHRHQGZPC-KIWGSFCNSA-N acetic acid;(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-aminopentanedioic acid;(2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FHEAIOHRHQGZPC-KIWGSFCNSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960002964 adalimumab Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 229940015979 epipen Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229960003776 glatiramer acetate Drugs 0.000 description 1
- 229940127560 insulin pen Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
L'invention concerne un système d'administration de médicaments comprenant : un serveur médical conçu pour envoyer, recevoir et traiter des données ; un dispositif de médication configuré pour administrer un médicament présélectionné ; un circuit de capteur configuré pour détecter des paramètres sélectionnés relatifs à l'administration de médicaments et transmettre des informations ; et un hub de transmission configuré pour communiquer avec le serveur médical et le circuit du capteur. Le hub de transmission est configuré pour recevoir un signal du circuit de capteur et échanger les informations. Une application est configurée pour faciliter l'échange d'informations entre le circuit du capteur et le serveur médical. L'application comprend un ensemble présélectionné de protocoles. L'application permet de surveiller l'utilisation du dispositif de médication et l'emplacement du dispositif de médication en se connectant au dispositif de médication par le biais du hub de transmission.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/483,572 | 2014-09-11 | ||
| US14/483,572 US9692829B2 (en) | 2012-12-03 | 2014-09-11 | Medication delivery system and method |
| PCT/US2015/049232 WO2016040512A1 (fr) | 2014-09-11 | 2015-09-09 | Système et procédé d'administration de médicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2960519A1 true CA2960519A1 (fr) | 2016-03-17 |
Family
ID=55459534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2960519A Abandoned CA2960519A1 (fr) | 2014-09-11 | 2015-09-09 | Systeme et procede d'administration de medicaments |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3191972A4 (fr) |
| JP (2) | JP6766034B2 (fr) |
| CN (1) | CN107077451A (fr) |
| AU (1) | AU2015315181A1 (fr) |
| CA (1) | CA2960519A1 (fr) |
| RU (1) | RU2017107745A (fr) |
| WO (1) | WO2016040512A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9692829B2 (en) | 2012-12-03 | 2017-06-27 | Mylan Inc. | Medication delivery system and method |
| US20140155827A1 (en) | 2012-12-03 | 2014-06-05 | Mylan, Inc. | Medicament information system and method |
| GB2606087B (en) | 2016-06-06 | 2023-03-08 | E3D Agricultural Cooporative Association Ltd | Multiple use computerized injector |
| WO2019129617A1 (fr) | 2017-12-28 | 2019-07-04 | Sanofi | Ensemble de conditionnement |
| US20240226464A1 (en) * | 2019-09-25 | 2024-07-11 | Janssen Pharmaceuticals, Inc. | Drug delivery adjustment |
| AU2020354698A1 (en) * | 2019-09-25 | 2022-05-19 | Janssen Pharmaceuticals, Inc. | Drug delivery systems and methods |
| KR20220069978A (ko) * | 2019-09-25 | 2022-05-27 | 얀센 파마슈티칼즈, 인코포레이티드 | 외부 시스템 및/또는 기타 장치들과 통신하는 약물 투여 장치 |
| KR20220088701A (ko) * | 2019-09-25 | 2022-06-28 | 얀센 파마슈티칼즈, 인코포레이티드 | 약물 투여 시스템의 상호 연결 |
| CN119258335A (zh) * | 2019-09-25 | 2025-01-07 | 杨森制药公司 | 测量与药物施用相关联的参数和结合参数测量的药物施用装置 |
| WO2023084479A2 (fr) * | 2021-11-15 | 2023-05-19 | Tech Pharmacy Services, Llc | Cyberprotection pour systèmes de distribution de produits pharmaceutiques |
| CN114053071A (zh) * | 2021-11-16 | 2022-02-18 | 中国医学科学院肿瘤医院深圳医院 | 一种智能护理工作台 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002152309A (ja) * | 2000-11-15 | 2002-05-24 | Sharp Corp | Ｂｌｕｅｔｏｏｔｈ機器 |
| JP3308972B1 (ja) * | 2001-01-16 | 2002-07-29 | 有限会社セルフセキュリティ | 服薬確認支援装置 |
| JP2004280455A (ja) * | 2003-03-14 | 2004-10-07 | Toshiba Corp | 医療情報システム |
| US20040210488A1 (en) * | 2003-04-17 | 2004-10-21 | Doherty James M. | Internet Pharmacy Dispenser |
| KR100906176B1 (ko) * | 2003-11-25 | 2009-07-03 | 인터내셔널 비지네스 머신즈 코포레이션 | 모바일 허브 및 모바일 허브에서의 이벤트 관리 방법 |
| US8361026B2 (en) * | 2005-02-01 | 2013-01-29 | Intelliject, Inc. | Apparatus and methods for self-administration of vaccines and other medicaments |
| US8126733B2 (en) * | 2006-10-24 | 2012-02-28 | Medapps, Inc. | Systems and methods for medical data interchange using mobile computing devices |
| JPWO2008117544A1 (ja) * | 2007-03-28 | 2010-07-15 | 日本電気株式会社 | 内包物管理デバイス、内包物管理デバイス製造装置、内包物管理デバイス製造方法、及び内包物管理方法 |
| US9550031B2 (en) * | 2008-02-01 | 2017-01-24 | Reciprocal Labs Corporation | Device and method to monitor, track, map, and analyze usage of metered-dose inhalers in real-time |
| JP2009258941A (ja) * | 2008-04-16 | 2009-11-05 | Tokyo Institute Of Technology | 治験データ収集システム |
| EP2349412B1 (fr) * | 2008-10-01 | 2019-07-24 | Novo Nordisk A/S | Moyen de collecte de données pour dispositif médical |
| US8716667B2 (en) * | 2009-04-06 | 2014-05-06 | Sony Corporation | Switching apparatus, switching method, and electronic device |
| US9656092B2 (en) * | 2009-05-12 | 2017-05-23 | Chronicmobile, Inc. | Methods and systems for managing, controlling and monitoring medical devices via one or more software applications functioning in a secure environment |
| US20110021140A1 (en) * | 2009-07-22 | 2011-01-27 | Boston Life Labs | Method and apparatus for providing home healthcare services using a sensor network |
| KR101689242B1 (ko) * | 2011-04-21 | 2016-12-23 | 엠파이어 테크놀로지 디벨롭먼트 엘엘씨 | 모바일 장치를 사용하는 위치 소셜 네트워킹 |
| US20130246083A1 (en) * | 2012-03-16 | 2013-09-19 | Alexion Pharmaceuticals, Inc. | Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitor |
| US20130262184A1 (en) * | 2012-03-30 | 2013-10-03 | Arbitron Inc. | Systems and Methods for Presence Detection and Linking to Media Exposure Data |
| WO2013156510A1 (fr) * | 2012-04-17 | 2013-10-24 | Novo Nordisk A/S | Dispositif d'administration de médicaments comprenant un élément d'identification de régime posologique |
| US9049998B2 (en) * | 2012-06-22 | 2015-06-09 | Fitbit, Inc. | Biometric monitoring device with heart rate measurement activated by a single user-gesture |
| US8768673B2 (en) * | 2012-07-26 | 2014-07-01 | Rimidi Diabetes, Inc. | Computer-implemented system and method for improving glucose management through cloud-based modeling of circadian profiles |
| US9196139B2 (en) * | 2012-09-12 | 2015-11-24 | ACCO Brands Corporation | Proximity tag for object tracking |
| JP6021105B2 (ja) * | 2012-10-19 | 2016-11-02 | 株式会社プロップ | 服薬管理システム |
| US20140155827A1 (en) * | 2012-12-03 | 2014-06-05 | Mylan, Inc. | Medicament information system and method |
| US9692829B2 (en) * | 2012-12-03 | 2017-06-27 | Mylan Inc. | Medication delivery system and method |
-
2015
- 2015-09-09 AU AU2015315181A patent/AU2015315181A1/en not_active Abandoned
- 2015-09-09 JP JP2017513411A patent/JP6766034B2/ja not_active Expired - Fee Related
- 2015-09-09 CA CA2960519A patent/CA2960519A1/fr not_active Abandoned
- 2015-09-09 EP EP15840938.3A patent/EP3191972A4/fr not_active Ceased
- 2015-09-09 RU RU2017107745A patent/RU2017107745A/ru not_active Application Discontinuation
- 2015-09-09 WO PCT/US2015/049232 patent/WO2016040512A1/fr not_active Ceased
- 2015-09-09 CN CN201580048532.5A patent/CN107077451A/zh active Pending
-
2019
- 2019-11-29 JP JP2019216502A patent/JP2020053078A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016040512A1 (fr) | 2016-03-17 |
| RU2017107745A (ru) | 2018-10-11 |
| EP3191972A4 (fr) | 2018-03-14 |
| JP6766034B2 (ja) | 2020-10-07 |
| JP2017529920A (ja) | 2017-10-12 |
| AU2015315181A1 (en) | 2017-03-30 |
| CN107077451A (zh) | 2017-08-18 |
| JP2020053078A (ja) | 2020-04-02 |
| EP3191972A1 (fr) | 2017-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9807174B2 (en) | Medication delivery system and method | |
| CA2960519A1 (fr) | Systeme et procede d'administration de medicaments | |
| US10420623B2 (en) | Medicament information system and method | |
| US10460836B2 (en) | Medical device system and method for establishing wireless communication | |
| EP3310412B1 (fr) | Système médical avec appareil de commande pour la disposition des données de contrôl et procedé pour fournir des données de contrôl | |
| KR101732631B1 (ko) | 모바일 기기 기반 복약 관리 시스템 | |
| CN105814572A (zh) | 能够根据摄入计划来监视由用户进行的产品的摄入的记录系统和登记数据的方法 | |
| CN114375208B (zh) | 用于医疗设备的双模式地理围栏 | |
| US12357537B2 (en) | Locking cap assembly | |
| US20220280391A1 (en) | Medication dispensing machine and system | |
| KR20160011930A (ko) | 약물 복용 관리 방법 및 이 약물을 복용하는 환자 관리 방법 | |
| US20250339339A1 (en) | Locking cap assembly | |
| TWI686191B (zh) | 群組式用藥提醒系統 | |
| HK40007655A (en) | Injection monitoring device and system | |
| HK1254069B (zh) | 用於控制医学系统的控制装置和方法、便携式设备、装置和计算机程序产品 | |
| TW201914568A (zh) | 智慧型藥品管理系統 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20200716 |
|
| FZDE | Discontinued |
Effective date: 20230109 |
|
| FZDE | Discontinued |
Effective date: 20230109 |
|
| FZDE | Discontinued |
Effective date: 20230109 |